Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Neutralizing | 10 | 2017 | 112 | 1.930 |
Why?
|
| HIV-1 | 9 | 2017 | 163 | 1.620 |
Why?
|
| HIV Antibodies | 7 | 2017 | 25 | 1.300 |
Why?
|
| HIV Infections | 9 | 2017 | 772 | 0.990 |
Why?
|
| Virus Latency | 1 | 2014 | 33 | 0.490 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1135 | 0.350 |
Why?
|
| Viral Load | 5 | 2017 | 150 | 0.250 |
Why?
|
| Immunotherapy | 2 | 2014 | 629 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2016 | 425 | 0.150 |
Why?
|
| HLA-B27 Antigen | 1 | 2017 | 8 | 0.150 |
Why?
|
| HLA-B Antigens | 1 | 2017 | 35 | 0.150 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2014 | 17 | 0.130 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2014 | 18 | 0.130 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2014 | 19 | 0.130 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2014 | 16 | 0.130 |
Why?
|
| Receptors, Fc | 1 | 2014 | 33 | 0.120 |
Why?
|
| Hydroxamic Acids | 1 | 2014 | 49 | 0.120 |
Why?
|
| CTLA-4 Antigen | 1 | 2014 | 135 | 0.120 |
Why?
|
| Remission Induction | 1 | 2016 | 722 | 0.120 |
Why?
|
| HIV | 1 | 2013 | 46 | 0.120 |
Why?
|
| Anti-Retroviral Agents | 1 | 2013 | 30 | 0.120 |
Why?
|
| Animals | 8 | 2017 | 26590 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2017 | 615 | 0.110 |
Why?
|
| Mice | 6 | 2017 | 11356 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2012 | 89 | 0.110 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 149 | 0.100 |
Why?
|
| Mice, Inbred NOD | 3 | 2016 | 187 | 0.090 |
Why?
|
| Humans | 10 | 2017 | 86678 | 0.070 |
Why?
|
| Neutralization Tests | 2 | 2017 | 77 | 0.060 |
Why?
|
| Immunization, Passive | 2 | 2016 | 71 | 0.060 |
Why?
|
| Epitopes | 2 | 2017 | 255 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2017 | 485 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 1540 | 0.050 |
Why?
|
| Cell Line | 2 | 2016 | 2469 | 0.050 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 2 | 0.040 |
Why?
|
| Viremia | 1 | 2017 | 55 | 0.040 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2016 | 12 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2016 | 52 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 229 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 2014 | 94 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 5214 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 64 | 0.030 |
Why?
|
| Dependovirus | 1 | 2013 | 33 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 376 | 0.030 |
Why?
|
| Virion | 1 | 2013 | 59 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2013 | 19 | 0.030 |
Why?
|
| AIDS Vaccines | 1 | 2013 | 9 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 164 | 0.030 |
Why?
|
| Half-Life | 1 | 2012 | 96 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2013 | 265 | 0.030 |
Why?
|
| Mutation | 2 | 2014 | 3968 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2012 | 129 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 543 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 273 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2013 | 498 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2012 | 94 | 0.030 |
Why?
|
| Clone Cells | 1 | 2012 | 213 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 231 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 408 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 536 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 425 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2014 | 459 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 724 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2012 | 81 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 196 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 339 | 0.030 |
Why?
|
| Ligands | 1 | 2012 | 433 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 895 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 930 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2013 | 425 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2768 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 853 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 1924 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1683 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1457 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2062 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1286 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3030 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 1376 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2231 | 0.020 |
Why?
|
Halper-Stromberg's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(80)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_